A retrospective, single-center case series evaluating the use of BRAF inhibitors in adult patients with BRAFV600E- LCH proven by biopsy
Latest Information Update: 18 Jul 2021
At a glance
- Drugs Dabrafenib (Primary) ; Vemurafenib (Primary)
- Indications Langerhans cell histiocytosis
- Focus Therapeutic Use
Most Recent Events
- 18 Jul 2021 New trial record